Balyasny Asset Management’s Cellectar Biosciences CLRB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$405K Hold
220,000
– – ﹤0.01% 2641
2026
Q2
$612K Buy
+220,000
New +$615K ﹤0.01% 2441

Other funds holding CLRB

Balyasny Asset Management's CLRB Position: Q3 2026 in Review

Balyasny Asset Management held its Cellectar Biosciences (CLRB) position steady in Q3 2026 at 220,000 shares worth $405K. The position accounts for ﹤0.01% of the portfolio, ranked #2641.

Balyasny Asset Management first reported a position in CLRB in Q2 2026 and has held it in 2 quarters since. The position peaked at $612K in Q2 2026. 28 funds tracked by Wall St. Rank hold CLRB as of Q3 2026.

  • Balyasny Asset Management held 220,000 shares of Cellectar Biosciences worth $405K as of Q3 2026.
  • Balyasny Asset Management left its Cellectar Biosciences share count unchanged in Q3 2026.
  • Cellectar Biosciences made up ﹤0.01% of Balyasny Asset Management's portfolio in Q3 2026, its #2641 holding.
  • Balyasny Asset Management first reported a position in Cellectar Biosciences in Q2 2026 and has held it in 2 quarters since.
  • Balyasny Asset Management's Cellectar Biosciences position peaked at $612K in Q2 2026.
  • 28 funds tracked by Wall St. Rank held Cellectar Biosciences as of Q3 2026.

Based on Balyasny Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.